Results 101 to 110 of about 122,821 (160)

Effect of Perioperative Nicorandil on Myocardial Protection in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass, a Retrospective Study. [PDF]

Drug Des Devel Ther
Chen Y, Liu Y, Lv H, Li Q, Shen J, Chen W, Shi J, Zhou C.   +7 more
europepmc   +1 more source

Myocardial protection in paediatric cardiac surgery: building an evidence-based strategy. [PDF]

Ann R Coll Surg Engl
Drury NE.
europepmc   +1 more source

Efficacy of electroacupuncture on myocardial protection and postoperative rehabilitation in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and Meta-analysis. [PDF]

J Tradit Chin Med
Xiaoyu Q, Chunai W, Jianjun X, Jie Z, Xiaoting LU, Shengshuang D, Long GE, Minzhen W.   +7 more
europepmc   +1 more source

Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass. [PDF]

Ann Thorac Cardiovasc Surg
Yuan B, Huang X, Wen J, Peng M.
europepmc   +1 more source

[Myocardial protection].

Arquivos brasileiros de cardiologia, 1991
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adenosine and myocardial protection

Journal of Cardiothoracic and Vascular Anesthesia, 1993
A DENOSINE (ADO, MW = 267.24) is an endogenous nucleoside (Fig I), which is the end-product of highenergy adenosine triphosphatc (ATP) catabolism during reduced oxygen (02) supply/demand states resulting from hypoxia and ischemia.’ In regard to the cardiovascular system, ADO may be considered a self-protective hormone or autocoid, because it is ...
H B Bärner
exaly   +3 more sources

Myocardial Protection

Journal of Cardiac Surgery, 1986
Early studies of myocardial protection were designed to minimize ischemic injury. The next class and generation of investigations will most likely be designed to accelerate recovery following known myocardial injury. Such techniques will play an important role in allowing operations on acutely injured and ischemic myocardium and will be important in ...
A S, Wechsler, A S, Abd-Elfattah, C E, Murphy, D R, Salter, L A, Brunsting, J P, Goldstein   +5 more
openaire   +2 more sources

Myocardial protection and cardioplegia

Current Opinion in Cardiology, 1993
Over the past year there has been a tremendous enthusiasm for the novel technique of warm heart surgery. In contradistinction to hypothermic myocardial preservation, warm cardiac surgery provides for operative repair in a nonischemic heart. Warm cardioplegia can be administered in an antegrade or retrograde manner, continuously, and perhaps even ...
I B, Krukenkamp, S, Levitsky
openaire   +2 more sources

Myocardial Protection with Carvedilol

Journal of Cardiovascular Pharmacology, 1992
Carvedilol is a multiple-action cardiovascular agent that is both a beta-adrenoceptor antagonist and a vasodilator and has recently been made available for the treatment of mild-to-moderate hypertension. Clinical trials are ongoing to establish the efficacy of carvedilol in angina and congestive heart failure. beta-Adrenoceptor antagonists are known to
G Z, Feuerstein, S A, Hamburger, E F, Smith, A, Bril, R R, Ruffolo   +4 more
openaire   +2 more sources

Myocardial protection for transplantation

Transplantation Proceedings, 1999
PROGRESS in the development of new techniques in surgery of heart transplantation had considerable influence on the creation of new methods for heart preservation. Currently, various cardioplegic solutions, developed for cardiac surgery, provide safe preservation of myocardial function for 5 to 6 hours, but remain unsatisfactory.
M, Garlicki, J, Kołcz, P, Rudziński, B, Kapelak, J, Sadowski, S, Wójcik, E, Pietrzyk, W, Frasik, J, Drukała, A, Dziatkowiak   +9 more
openaire   +2 more sources